Inhibition of tumour necrosis factor (TNF) production by antimalarial drugs used in cerebral malaria.
Kwiatkowski
D
D
Department of Paediatrics, John Radcliffe Hospital, Oxford, UK.
Bate
C
C
D000962:Antimalarials / Q000627:therapeutic use*; D000077549:Artemether; D037621:Artemisinins; D002738:Chloroquine / Q000627:therapeutic use; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016779:Malaria, Cerebral / Q000188:drug therapy* / Q000378:metabolism; D011803:Quinine / Q000627:therapeutic use; D012717:Sesquiterpenes / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000096:biosynthesis*
D000962:Antimalarials; D037621:Artemisinins; D012717:Sesquiterpenes; D014409:Tumor Necrosis Factor-alpha; D002738:Chloroquine; D011803:Quinine; D000077549:Artemether